vs

Side-by-side financial comparison of FRP HOLDINGS, INC. (FRPH) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $10.9M, roughly 1.3× FRP HOLDINGS, INC.). On growth, FRP HOLDINGS, INC. posted the faster year-over-year revenue change (3.6% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 3.8%).

FRP Advisory is a business advisory firm based in the United Kingdom, providing restructuring, corporate finance, debt advisory, forensic accounting and financial advisory and is one of the UK’s largest specialists in the area of corporate restructuring.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

FRPH vs IRIX — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.3× larger
IRIX
$14.7M
$10.9M
FRPH
Growing faster (revenue YoY)
FRPH
FRPH
+73.4% gap
FRPH
3.6%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
3.8%
FRPH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FRPH
FRPH
IRIX
IRIX
Revenue
$10.9M
$14.7M
Net Profit
$139.0K
Gross Margin
37.2%
Operating Margin
15.4%
Net Margin
1.3%
Revenue YoY
3.6%
-69.7%
Net Profit YoY
-91.8%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRPH
FRPH
IRIX
IRIX
Q4 25
$10.9M
$14.7M
Q3 25
$10.8M
$12.5M
Q2 25
$10.8M
$13.6M
Q1 25
$10.3M
$11.9M
Q4 24
$10.5M
$12.7M
Q3 24
$10.6M
$11.6M
Q2 24
$10.5M
$12.6M
Q1 24
$10.1M
$11.8M
Net Profit
FRPH
FRPH
IRIX
IRIX
Q4 25
$139.0K
Q3 25
$662.0K
$-1.6M
Q2 25
$578.0K
$-994.0K
Q1 25
$1.7M
$-1.7M
Q4 24
$1.7M
$-834.0K
Q3 24
$1.4M
$-1.9M
Q2 24
$2.0M
$-2.7M
Q1 24
$1.3M
$-3.5M
Gross Margin
FRPH
FRPH
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
FRPH
FRPH
IRIX
IRIX
Q4 25
15.4%
Q3 25
12.6%
-11.3%
Q2 25
15.3%
-6.9%
Q1 25
22.6%
-1.7%
Q4 24
27.7%
-3.9%
Q3 24
29.0%
-16.1%
Q2 24
26.9%
-20.9%
Q1 24
28.4%
-28.0%
Net Margin
FRPH
FRPH
IRIX
IRIX
Q4 25
1.3%
Q3 25
6.1%
-12.6%
Q2 25
5.3%
-7.3%
Q1 25
16.6%
-14.2%
Q4 24
16.0%
-6.6%
Q3 24
12.8%
-16.7%
Q2 24
19.5%
-21.2%
Q1 24
12.8%
-29.5%
EPS (diluted)
FRPH
FRPH
IRIX
IRIX
Q4 25
$0.03
Q3 25
$0.03
$-0.09
Q2 25
$0.03
$-0.06
Q1 25
$0.09
$-0.10
Q4 24
$0.09
$-0.05
Q3 24
$0.07
$-0.12
Q2 24
$0.11
$-0.16
Q1 24
$0.07
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRPH
FRPH
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
$192.6M
Stockholders' EquityBook value
$428.5M
Total Assets
$735.1M
$29.2M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRPH
FRPH
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$134.9M
$5.6M
Q2 25
$153.2M
$6.8M
Q1 25
$142.9M
$7.2M
Q4 24
$148.6M
$2.4M
Q3 24
$144.7M
$3.9M
Q2 24
$156.9M
$4.1M
Q1 24
$152.5M
$5.4M
Total Debt
FRPH
FRPH
IRIX
IRIX
Q4 25
$192.6M
Q3 25
$185.3M
Q2 25
$180.4M
Q1 25
$178.3M
Q4 24
$178.9M
$1.0M
Q3 24
$178.8M
$1.4M
Q2 24
$178.8M
Q1 24
$178.7M
Stockholders' Equity
FRPH
FRPH
IRIX
IRIX
Q4 25
$428.5M
Q3 25
$427.7M
$4.7M
Q2 25
$426.7M
$6.1M
Q1 25
$425.2M
$852.0K
Q4 24
$423.1M
$2.1M
Q3 24
$420.9M
$2.6M
Q2 24
$419.1M
$4.2M
Q1 24
$416.1M
$6.5M
Total Assets
FRPH
FRPH
IRIX
IRIX
Q4 25
$735.1M
$29.2M
Q3 25
$731.3M
$28.4M
Q2 25
$722.8M
$31.6M
Q1 25
$717.1M
$34.2M
Q4 24
$728.5M
$29.1M
Q3 24
$726.9M
$30.2M
Q2 24
$711.9M
$31.2M
Q1 24
$705.7M
$34.1M
Debt / Equity
FRPH
FRPH
IRIX
IRIX
Q4 25
0.45×
Q3 25
0.43×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.42×
0.48×
Q3 24
0.42×
0.53×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRPH
FRPH
IRIX
IRIX
Operating Cash FlowLast quarter
$29.7M
Free Cash FlowOCF − Capex
$-21.5M
FCF MarginFCF / Revenue
-196.6%
Capex IntensityCapex / Revenue
468.5%
Cash ConversionOCF / Net Profit
213.50×
TTM Free Cash FlowTrailing 4 quarters
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRPH
FRPH
IRIX
IRIX
Q4 25
$29.7M
Q3 25
$8.1M
$-1.2M
Q2 25
$8.7M
$-397.0K
Q1 25
$4.5M
$-1.1M
Q4 24
$29.0M
$-1.2M
Q3 24
$6.3M
$-3.1M
Q2 24
$12.2M
$-1.3M
Q1 24
$2.9M
$-1.6M
Free Cash Flow
FRPH
FRPH
IRIX
IRIX
Q4 25
$-21.5M
Q3 25
$-16.9M
$-1.2M
Q2 25
$2.6M
$-410.0K
Q1 25
$1.4M
$-1.2M
Q4 24
$-22.2M
$-1.2M
Q3 24
$-28.2M
$-3.1M
Q2 24
$5.9M
Q1 24
$-3.3M
$-1.7M
FCF Margin
FRPH
FRPH
IRIX
IRIX
Q4 25
-196.6%
Q3 25
-157.0%
-9.4%
Q2 25
24.0%
-3.0%
Q1 25
13.6%
-9.8%
Q4 24
-210.9%
-9.8%
Q3 24
-265.7%
-26.5%
Q2 24
56.0%
Q1 24
-32.6%
-14.0%
Capex Intensity
FRPH
FRPH
IRIX
IRIX
Q4 25
468.5%
Q3 25
232.0%
0.1%
Q2 25
55.9%
0.1%
Q1 25
30.1%
0.1%
Q4 24
486.1%
0.1%
Q3 24
325.1%
0.0%
Q2 24
60.3%
0.0%
Q1 24
61.2%
0.0%
Cash Conversion
FRPH
FRPH
IRIX
IRIX
Q4 25
213.50×
Q3 25
12.21×
Q2 25
15.00×
Q1 25
2.63×
Q4 24
17.18×
Q3 24
4.65×
Q2 24
5.96×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRPH
FRPH

Other$5.6M51%
Multifamily Segment$5.3M49%

IRIX
IRIX

Segment breakdown not available.

Related Comparisons